Can a new Immune-Boosting pill make immunotherapy work better against Hard-to-Treat tumors?
Disease control
Recruiting now
This study tests an experimental drug called PTT-936, which activates a protein (ALPK1) that may help the immune system attack cancer. The trial includes adults with advanced or metastatic solid tumors that cannot be removed by surgery. In the first part, patients receive PTT-936…
Phase: PHASE1, PHASE2 • Sponsor: Pyrotech Therapeutics, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC